Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? [1]

American Heart Journal

Volumn 149, Issue 3, 2005, Pages

  Al Shaer, Moutasim H ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; NICOTINIC ACID; SIMVASTATIN; URIC ACID; LOVASTATIN NIACIN COMBINATION; LOVASTATIN-NIACIN COMBINATION; MEVINOLIN;

DYSLIPIDEMIA; GOUT; HUMAN; HYPERURICEMIA; LETTER; METABOLIC DISORDER; PRIORITY JOURNAL; TREATMENT INDICATION; URIC ACID BLOOD LEVEL; DRUG COMBINATION; METABOLIC SYNDROME X; METABOLISM; NOTE;

DRUG COMBINATIONS; HUMANS; LOVASTATIN; METABOLIC SYNDROME X; NIACIN; URIC ACID;

EID: 17844379216     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.016     Document Type: Letter

References (5)

1. H.J. Milionis A.I. Kakafika S.G. Tsouli Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia Am. Heart J. 148 2004 635 640
2. S.M. Grundy J.I. Cleeman C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation 110 2004 227 239
3. Physician desk reference (PDR), 2004.
4. Z.N. Gaut R. Pocelinko H.M. Solomon Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid Metabolism 20 1971 1031 1035
5. B.E. Klein R. Klein K.E. Lee Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam Diabetes Care 25 2002 1790 1794